Arcinova Appoints Roger Kilburn as CEO

Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova
Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova

UK-based contract development and manufacturing organization (CDMO) Arcinova has appointed Roger Kilburn as its new CEO, effective immediately. The previous CEO, Ian Shott, has assumed the position of executive chairman.

Kilburn has more than 25 years of international experience in the pharmaceutical and chemical industries. He has worked in a variety of roles within general management, marketing, sales, manufacturing, projects and engineering. Prior to his most recent position as CEO of IBioIC, Kilburn worked for Johnson Matthey and ICI in business leader positions. He holds a 1st class honors degree in chemical engineering from the University of Glamorgan.

Ian Shott commented, “I am delighted that Roger is taking over this crucial role and certain that his experience leading both Macfarlan Smith in Edinburgh and JM Pharma Services in Boston, Massachusetts gives him an excellent foundation to steer Arcinova through its critical scale up phase, creating a strong and sustainable medium sized enterprise.”

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.